Linking Epigenomics With Prescription Opioid Abuse and High Impact Musculoskeletal Pain (LEAP)
Sponsor: Florida Medical Malpractice Joint Underwriting Association
A observational or N/A phase clinical study on Pain, Chronic and Prescription Drug Abuse (Not Dependent), this trial is completed. The trial is conducted by Florida Medical Malpractice Joint Underwriting Association and has accumulated 13 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2023 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Jul 2022 — Sep 2023 [monthly]
Recruiting
-
Dec 2021 — Jul 2022 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Apr 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jul 2020 — Nov 2020 [monthly]
Recruiting
-
Nov 2019 — Jul 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2019 — Nov 2019 [monthly]
Not Yet Recruiting
-
Aug 2019 — Sep 2019 [monthly]
Not Yet Recruiting
-
Jun 2019 — Aug 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Florida Medical Malpractice Joint Underwriting Association
- University of Florida
For direct contact, visit the study record on ClinicalTrials.gov .